Assenagon Asset Management S.A. Boosts Position in Stoke Therapeutics, Inc. $STOK

Assenagon Asset Management S.A. boosted its holdings in Stoke Therapeutics, Inc. (NASDAQ: STOK) by 36.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,227,723 shares of the company's stock after purchasing an additional 327,451 shares during the quarter. Assenagon Asset Management